Brain Arteriovenous Malformations (AVMs) in Children

Status: draft · Last updated 2026-11-03 · By Jason S. Hauptman, MD, PhD (AI-assisted)

Read in the interactive book →

High-yield points

  • Children usually present with hemorrhage (about 60–80%), and AVMs are the leading cause of spontaneous hemorrhage in children .
  • Annual hemorrhage risk is about 2%, similar to adults once you adjust for presentation, but children have decades of exposure .
  • ARUBA was adults only. Most pediatric centers aim for cure when it is safe .
  • Grade with both scales: Spetzler–Martin plus the supplementary grade. Young age favors surgery .
  • Surgery cures low-grade AVMs. SRS obliterates about 63% after a latency with ongoing bleeding risk. Embolization is an adjunct .
  • Recurrence is about 11% in children: keep imaging (including angiography) for years after cure .

Landmark papers

  • ARUBA (Mohr et al., Lancet 2014): adults 18 and older with unruptured AVMs. Medical management alone beat intervention for death or stroke at 33 months (10.1% vs 30.7%); children were not included .
  • KRAS mutations (Nikolaev et al., N Engl J Med 2018): somatic activating KRAS mutations were found in AVM tissue from 45 of 72 patients and in none of their blood samples .
  • Children vs adults (Fullerton et al., Stroke 2005): after adjusting for presentation, children's subsequent hemorrhage rate was lower (HR 0.10) .

Brain AVMs are the leading cause of spontaneous intracranial hemorrhage in children . Compared with adults, children more often present with rupture and are more likely to recur after apparent cure. Because they have decades of risk ahead, cure (complete obliteration) is the goal whenever it can be achieved safely.

Jason S. Hauptman, MD, PhD© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure from Hauptman's High Yield Thoughts in Pediatric Neurosurgery (pedsneurosurg.org). Do not copy, reproduce, redistribute or adapt without written permission.https://www.pedsneurosurg.org/hy-peds-ns:avm:c2c55cefd9619179© 2026 Jason S. Hauptman, MD, PhD. All rights reserved. Original figure; please do not copy, reproduce or redistribute without written permission.Brain arteriovenous malformation in a coronal slab of the left hemisphere: feeding arteries, a compact nidus, superficial drainage by a cortical vein to the superior sagittal sinus, and deep drainage to the internal cerebral veinCORONAL SLAB, LEFT HEMISPHEREsizesuperficialdrainage:cortical veinto the SSSnidus: isthe overlyingcortexeloquent?deepdrainage(raises thegrade)feeding arteries
Brain AVM in a coronal section: feeding arteries (red) enter a tangled nidus, which drains through arterialized veins (purple) to a superficial cortical vein and to the deep venous system. The Spetzler–Martin grade scores nidus size, the eloquence of surrounding brain, and deep venous drainage. Not to scale.

Biology and presentation

Natural history

Grading

Treatment

Recurrence after "cure": image long term

Related topics

References

  1. Garcia JH, Rutledge C, Winkler EA, et al. Validation of the Ruptured Arteriovenous Malformation Grading Scale in a pediatric cohort. J Neurosurg Pediatr 2022;29(5):575–579. doi:10.3171/2022.1.PEDS21466. PMID 35213838. verified
  2. Nikolaev SI, Vetiska S, Bonilla X, et al. Somatic activating KRAS mutations in arteriovenous malformations of the brain. N Engl J Med 2018;378(3):250–261. doi:10.1056/NEJMoa1709449. PMID 29298116. verified
  3. de Oliveira Manduca Palmiero H, Gadelha Figueiredo E. Management of pediatric brain arteriovenous malformation: a systematic review of retrospective studies. Neurosurg Rev 2026;49(1):424. doi:10.1007/s10143-026-04346-2. PMID 42204010. verified
  4. Winkler EA, Lu A, Morshed RA, et al. Bringing high-grade arteriovenous malformations under control: clinical outcomes following multimodality treatment in children. J Neurosurg Pediatr 2020;26(1):82–91. doi:10.3171/2020.1.PEDS19487. PMID 32276243. verified
  5. Pepper J, Lamin S, Thomas A, et al. Clinical features and outcome in pediatric arteriovenous malformation: institutional multimodality treatment. Childs Nerv Syst 2023;39(4):975–982. doi:10.1007/s00381-022-05800-4. PMID 36580118. verified
  6. Lu AY, Winkler EA, Garcia JH, et al. A comparison of incidental and symptomatic unruptured brain arteriovenous malformations in children. J Neurosurg Pediatr 2023;31(5):463–468. doi:10.3171/2023.1.PEDS22541. PMID 36805316. verified
  7. Fullerton HJ, Achrol AS, Johnston SC, et al. Long-term hemorrhage risk in children versus adults with brain arteriovenous malformations. Stroke 2005;36(10):2099–2104. doi:10.1161/01.STR.0000181746.77149.2b. PMID 16141419. verified
  8. Mohr JP, Parides MK, Stapf C, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet 2014;383(9917):614–621. doi:10.1016/S0140-6736(13)62302-862302-8). PMID 24268105. verified
  9. Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg 1986;65(4):476–483. doi:10.3171/jns.1986.65.4.0476. PMID 3760956. verified
  10. Lawton MT, Kim H, McCulloch CE, et al. A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery 2010;66(4):702–713. doi:10.1227/01.NEU.0000367555.16733.E1. PMID 20190666. verified
  11. Thrash GW, Evans RE, Sun Y, et al. Stereotactic radiosurgery treatment of pediatric arteriovenous malformations: a PRISMA systematic review and meta-analysis. Childs Nerv Syst 2025;41(1):188. doi:10.1007/s00381-025-06835-z. PMID 40407914. verified
  12. Burke RM, Chen CJ, Ding D, et al. Early obliteration of pediatric brain arteriovenous malformations after stereotactic radiosurgery: an international multicenter study. J Neurosurg Pediatr 2020;26(4):398–405. doi:10.3171/2020.4.PEDS19738. PMID 32590353. verified
  13. Calafiore R, Burke RM, Becerril-Gaitan A, et al. Characterization of pediatric infratentorial arteriovenous malformations: a retrospective, multicenter cohort study. Neurosurgery 2024;95(5):1064–1071. doi:10.1227/neu.0000000000002977. PMID 38700839. verified
  14. Shinya Y, Tos SM, Hajikarimloo B, et al. Efficacy and safety profile of volume-staged stereotactic radiosurgery for ruptured, large pediatric arteriovenous malformations: a multicenter cohort analysis. J Neurosurg Pediatr 2026;38(3):385–394. doi:10.3171/2026.1.PEDS25593. PMID 42284606. verified
  15. Hak JF, Boulouis G, Kerleroux B, et al. Pediatric brain arteriovenous malformation recurrence: a cohort study, systematic review and meta-analysis. J Neurointerv Surg 2022;14(6):611–617. doi:10.1136/neurintsurg-2021-017777. PMID 34583986. verified
  16. Jimenez JE, Gersey ZC, Wagner J, et al. Role of follow-up imaging after resection of brain arteriovenous malformations in pediatric patients: a systematic review of the literature. J Neurosurg Pediatr 2017;19(2):149–156. doi:10.3171/2016.9.PEDS16235. PMID 27911246. verified
  17. Oushy S, Gilder HE, Nesvick CL, et al. Delayed recurrence of pediatric arteriovenous malformations after radiologically confirmed obliteration. J Neurosurg Pediatr 2022;30(2):195–202. doi:10.3171/2022.4.PEDS21471. PMID 35623369. verified

Verification (2026-11-03): each reference's authors, title, journal, volume, pages, DOI and PMID were checked on PubMed, and every figure cited was checked against the PubMed abstract. Full texts were not reviewed. The Spetzler–Martin point values (size under 3, 3–6 and over 6 cm; eloquence; deep drainage) are the standard scheme but are not stated in reference 9's abstract, so they are given as standard teaching. The direction of the supplementary-grade age and hemorrhage points is inferred from the factors listed in reference 10's abstract. References 7 (mixed ages) and 8–10 (adults or mixed) are not pediatric-only. The "about 60–80%" hemorrhagic presentation range is this text's synthesis of references 4 and 5. Vein of Galen malformations are covered in their own topic. The schematic is an original figure.